Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Psychiatric Consultation for COVID-19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04395872
Recruitment Status : Not yet recruiting
First Posted : May 20, 2020
Last Update Posted : May 27, 2020
Sponsor:
Information provided by (Responsible Party):
Jonghun Lee, Daegu Catholic University Medical Center

Brief Summary:

In this study, the content and results of the psychiatric consultation on patients in Corona Care Ward were verified retroactively, and the effects of COVID-19 patients' emotional state and psychological support and crisis intervention were assessed on their emotional state.

Patients who are admitted to the COVID-19 care unit of the Catholic University of Daegu Hospital are subject to consultation with the psychiatrist. By retrospectively reviewing the medical records of the request and the results of the subjects, We collected Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings, medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS, P4, SF-36, SCL-90-R) This study evaluates whether there is a difference in psychological scale according to differences in socio-demographic status and medical severity, and compares psychological measures before and after referral to mental health medicine to evaluate the effectiveness of psychiatric counseling.


Condition or disease Intervention/treatment
Covid19 Psychiatric Problem Isolation, Social Behavioral: Psychiatric counseling

Detailed Description:

Patients and medical workers in the event of an pandemic infectious disease usually experience extreme fear, which requires quick and immediate management of mental health. In 2015, the risk of post-traumatic stress disorder in isolated MERS patients and medical staff was very high. Even 4 ~ 6 months after the quarantine was over, anxiety was still lingering in 3% percent of patients and anger in 6.4 % of patients. The negative emotions and stress experienced by the medical staff for MERS patients were characterized by such events as mistakes and delays caused by communication problems. Also, people who were not infected with MERS experienced anxiety at 7.6 percent and anger at 16.6 percent during the quarantine period.Therefore, the need for psychological support for infected patients, isolated people, medical staff and the general public had been proposed during these infectious disease fad periods since MERS. Since the recent spread of coronavirus infection-19 (COVID-19) that began in Wuhan, China in December 2019, thousands of confirmed and dozens of deaths have been reported in South Korea and the number is on the rise. Thus, quarantine measures are currently being taken in Korea to reduce and treat the spread of COVID-19. Thus, psychological support and crisis intervention are needed in the early stages of stressful times to reduce anxiety, depression and post-traumatic stress disorder. In response, Daegu Catholic university hospital psychiatry department conducted active psychiatric counseling for medical patients who are hospitalized in Corona's management hospital for confirmation of coronavirus infection. In this study, the content and results of the psychiatric consultation on patients in Corona Care Ward were verified retroactively, and the effects of COVID-19 patients' emotional state and psychological support and crisis intervention were assessed on their emotional state.

Patients who are admitted to the COVID-19 care unit of the Catholic University of Daegu Hospital are subject to consultation with the psychiatrist. By retrospectively reviewing the medical records of the request and the results of the subjects, We collected Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings, medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS, P4, SF-36, SCL-90-R) This study evaluates whether there is a difference in psychological scale according to differences in socio-demographic status and medical severity, and compares psychological psychological measures before and after referral to mental health medicine to evaluate the effectiveness of psychiatric counseling.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 54 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Psychiatric Consultation for COVID-19 Patients
Estimated Study Start Date : May 28, 2020
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2020

Group/Cohort Intervention/treatment
COVID-19
Among patients who were confirmed as COVID-19 and admitted to the COVID-19 management ward of Daegu Catholic University Hospital, patients who were consulted by the Department of psychiatry was selected as participants. Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings, medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS, P4, SF-36, SCL-90-R). were collected from participants. It evaluates whether there is a difference in the psychological scale according to the difference in participants' sociodemographic status and medical severity, and evaluates the effectiveness of psychiatric counseling by comparing clinical psychological measures before and after referral to department of psychiatry.
Behavioral: Psychiatric counseling
Patients who are admitted to the COVID-19 care unit of the Catholic University of Daegu Hospital are subject to consultation with the psychiatrist. By retrospectively reviewing the medical records of the request and the results of the subjects, We collected Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings, medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS, P4, SF-36, SCL-90-R) This study evaluates whether there is a difference in psychological scale according to differences in socio-demographic status and medical severity, and compares psychological psychological measures before and after referral to mental health medicine to evaluate the effectiveness of psychiatric counseling.




Primary Outcome Measures :
  1. Change of PHQ-9 (Patient Health Questionnaire-9) [ Time Frame: On admission and at the time of discharge, on average 2 months ]
    for assess depressive symptom

  2. Change of GAD-7 (Patient Health Questionnaire-9) [ Time Frame: On admission and at the time of discharge, on average 2 months ]
    for assess anxiety symptom

  3. Change of PC-PTSD-5 (Primary Care PTSD Screen for DSM-5) [ Time Frame: On admission and at the time of discharge, on average 2 months ]
    for assess PTSD symptom

  4. Change of AIS (Athens Insomnia Scale) [ Time Frame: On admission and at the time of discharge, on average 2 months ]
    for assess insomnia

  5. Change of P4 (P4 Suicidality Screener) [ Time Frame: On admission and at the time of discharge, on average 2 months ]
    for assess suicidal idea

  6. Change of SF-36 (Short Form Health Survey Questionnaire) [ Time Frame: On admission and at the time of discharge, on average 2 months ]
    for assess health associated QoL


Secondary Outcome Measures :
  1. Change of SCL-90-R [ Time Frame: On admission and at the time of discharge, on average 2 months ]
    for assess other psychiatric symptoms



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients who have been confirmed as COVID-19 and admitted to the management ward, and consulted with a psychiatrist by a physician.
Criteria

Inclusion Criteria:

  1. Patient admitted to the COVID-19 management ward of Daegu Catholic University Hospital
  2. Patients who were consulted with a psychiatrist by a physician.

Exclusion Criteria:

  1. When the subject is accompanied by a serious physical or neurological condition
  2. In case of brain damage or concussion with loss of consciousness at the time of treatment
  3. When it is difficult to understand psychological intervention due to the apparent decrease in intelligence at the time of treatment
  4. When it is difficult to understand psychological intervention and follow examination instructions due to noticeable sensory damage such as hearing and vision at the time of treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04395872


Contacts
Layout table for location contacts
Contact: geunhui Won, M.D. +82-53-650-4780 guenheu@hanmail.net

Sponsors and Collaborators
Daegu Catholic University Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Jonghun Lee, M.D., ph.D. Daegu Catholic University Medical Center
Publications:

Layout table for additonal information
Responsible Party: Jonghun Lee, M.D., Ph. D., Daegu Catholic University Medical Center
ClinicalTrials.gov Identifier: NCT04395872    
Other Study ID Numbers: CR-20-062
First Posted: May 20, 2020    Key Record Dates
Last Update Posted: May 27, 2020
Last Verified: May 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Data will be shared on request for proper reason.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Jonghun Lee, Daegu Catholic University Medical Center:
COVID-19
consultation
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases